Chromosome arm 8p and cancer:: a fragile hypothesis

被引:56
作者
Birnbaum, D
Adélaïde, J
Popovici, C
Charafe-Jauffret, E
Mozziconacci, MJ
Chaffanet, M
机构
[1] U119 INSERM, IFR57, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, Dept Mol Oncol, Marseille, France
关键词
D O I
10.1016/S1470-2045(03)01225-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosome arm 8p is one of the most frequently altered regions in human cancers. Several potential oncogenes and tumour suppressor genes have been identified but further investigations are needed to confirm which are bona fide oncogenic targets. In cancer cells, chromosome breaks may occur at fragile sites throughout the genome. Some fragile sites lie within genes that may have a role in cancer; the best example is FHIT at 3p14, which contains the fragile site FRA3B. We have found that chromosome breaks disrupt the NRG1 gene at 8p12 in breast and pancreatic cancers. We hypothesise that alteration of the NRG1 gene could occur through breakage at a non-common fragile site.
引用
收藏
页码:639 / 642
页数:4
相关论文
共 51 条
[31]   The 8p11 myeloproliferative syndrome:: A distinct clinical entity caused by constitutive activation of FGFR1 [J].
Macdonald, D ;
Reiter, A ;
Cross, NCP .
ACTA HAEMATOLOGICA, 2002, 107 (02) :101-107
[32]  
Meyer D, 1997, DEVELOPMENT, V124, P3575
[33]   Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors [J].
Morelli, C ;
Karayianni, E ;
Magnanini, C ;
Mungall, AJ ;
Thorland, E ;
Negrini, M ;
Smith, DI ;
Barbanti-Brodano, G .
ONCOGENE, 2002, 21 (47) :7266-7276
[34]   The ErbB signaling network: receptor heterodimerization in development and cancer [J].
Olayioye, MA ;
Neve, RM ;
Lane, HA ;
Hynes, NE .
EMBO JOURNAL, 2000, 19 (13) :3159-3167
[35]   FHIT:: from gene discovery to cancer treatment and prevention [J].
Pekarsky, Y ;
Zanesi, N ;
Palamarchuk, A ;
Huebner, K ;
Croce, CM .
LANCET ONCOLOGY, 2002, 3 (12) :748-754
[36]   Reciprocal translocations in breast tumor cell lines:: Cloning of a t(3;20) that targets the FHIT gene [J].
Popovici, C ;
Basset, C ;
Bertucci, F ;
Orsetti, A ;
Adélaide, J ;
Mozziconacci, MJ ;
Conte, N ;
Murati, A ;
Ginestier, C ;
Charafe-Jauffret, E ;
Ethier, SP ;
Lafage-Pochitaloff, M ;
Theillet, C ;
Birnbaum, D ;
Chaffanet, M .
GENES CHROMOSOMES & CANCER, 2002, 35 (03) :204-218
[37]   Fragile and unstable chromosomes in cancer: causes and consequences [J].
Richards, RI .
TRENDS IN GENETICS, 2001, 17 (06) :339-345
[38]   Common chromosomal fragile site FRA16D sequence:: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells [J].
Ried, K ;
Finnis, M ;
Hobson, L ;
Mangelsdorf, M ;
Dayan, S ;
Nancarrow, JK ;
Woollatt, E ;
Kremmidiotis, G ;
Gardner, A ;
Venter, D ;
Baker, E ;
Richards, RI .
HUMAN MOLECULAR GENETICS, 2000, 9 (11) :1651-1663
[39]   gamma-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175 [J].
Schaefer, G ;
Fitzpatrick, VD ;
Sliwkowski, MX .
ONCOGENE, 1997, 15 (12) :1385-1394
[40]   EVIDENCE FOR A 3RD BREAST-CANCER SUSCEPTIBILITY GENE [J].
SOBOL, H ;
BIRNBAUM, D ;
EISINGER, F .
LANCET, 1994, 344 (8930) :1151-1152